Palatin Technologies, Inc. (0KF3.L)
0KF3.L Stock Price Chart
Explore Palatin Technologies, Inc. interactive price chart. Choose custom timeframes to analyze 0KF3.L price movements and trends.
0KF3.L Company Profile
Discover essential business fundamentals and corporate details for Palatin Technologies, Inc. (0KF3.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
29 Jan 2018
Employees
30.00
Website
https://palatin.comCEO
Carl Spana
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.
0KF3.L Financial Timeline
Browse a chronological timeline of Palatin Technologies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 11 Feb 2026
Upcoming earnings on 12 Nov 2025
Upcoming earnings on 29 Sept 2025
Earnings released on 14 May 2025
EPS came in at -$0.18 falling short of the estimated -$0.17 by -5.88%.
Earnings released on 13 Feb 2025
EPS came in at -$0.12 surpassing the estimated -$0.42 by +71.43%.
Earnings released on 1 Oct 2024
EPS came in at -$0.51 surpassing the estimated -$0.56 by +8.11%, while revenue for the quarter reached $350.00K.
Earnings released on 26 Sept 2024
EPS came in at -$0.49, while revenue for the quarter reached $350.00K.
Earnings released on 15 May 2024
EPS came in at -$0.53 falling short of the estimated -$0.45 by -19.59%.
Earnings released on 28 Feb 2024
EPS came in at -$0.56 falling short of the estimated -$0.20 by -173.64%, while revenue for the quarter reached $2.03M, missing expectations by -67.67%.
Earnings released on 14 Nov 2023
EPS came in at -$0.48 falling short of the estimated -$0.41 by -19.46%, while revenue for the quarter reached $2.11M, missing expectations by -62.38%.
Earnings released on 28 Sept 2023
EPS came in at -$0.91 falling short of the estimated -$0.53 by -73.51%, while revenue for the quarter reached $1.76M, beating expectations by +33.65%.
Earnings released on 16 May 2023
EPS came in at -$0.63 falling short of the estimated -$0.36 by -72.08%, while revenue for the quarter reached $1.20M, missing expectations by -55.26%.
Earnings released on 14 Feb 2023
EPS came in at -$0.13 surpassing the estimated -$0.70 by +81.43%, while revenue for the quarter reached $1.03M, missing expectations by -35.19%.
Earnings released on 14 Nov 2022
EPS came in at -$0.86 surpassing the estimated -$1.19 by +27.73%, while revenue for the quarter reached $869.65K, beating expectations by +16.42%.
Earnings released on 22 Sept 2022
EPS came in at -$1.34 falling short of the estimated -$0.81 by -65.43%, while revenue for the quarter reached $770.74K, beating expectations by +298.66%.
Stock split effective on 8 Sept 2022
Shares were split 1:25, changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 31 Aug 2022
Shares were split 1:25, changing the number of shares outstanding and the price per share accordingly.
Earnings released on 16 May 2022
EPS came in at -$0.75 surpassing the estimated -$0.83 by +9.64%, while revenue for the quarter reached $216.10K, missing expectations by -28.37%.
Dividend declared on 15 Mar 2022
A dividend of $0.01 per share was announced, adjusted to $0.29.
Earnings released on 14 Feb 2022
EPS came in at -$1.00 falling short of the estimated -$0.75 by -33.33%, while revenue for the quarter reached $322.14K, beating expectations by +155.67%.
Earnings released on 15 Nov 2021
EPS came in at -$0.75 surpassing the estimated -$0.83 by +9.64%, while revenue for the quarter reached $159.48K.
Earnings released on 28 Sept 2021
EPS came in at -$1.50 falling short of the estimated -$0.75 by -100.00%, while revenue for the quarter reached $175.19K.
Earnings released on 14 May 2021
EPS came in at -$0.75 surpassing the estimated -$0.83 by +9.64%, while revenue for the quarter reached $88.74K.
Earnings released on 16 Feb 2021
EPS came in at -$1.00 falling short of the estimated -$0.58 by -72.41%, while revenue for the quarter reached -$163.97K.
Earnings released on 16 Nov 2020
EPS came in at -$0.50 falling short of the estimated -$0.25 by -100.00%, while revenue for the quarter reached -$288.56K.
Earnings released on 25 Sept 2020
EPS came in at -$0.75 falling short of the estimated -$0.58 by -29.31%.
0KF3.L Stock Performance
Access detailed 0KF3.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.